Select Medical Holdings Corporation (NYSE:SEM) Given Consensus Rating of “Moderate Buy” by Brokerages

Shares of Select Medical Holdings Corporation (NYSE:SEM) have received a consensus recommendation of “Moderate Buy” from the six research firms that are covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and four have given a buy rating to the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is $17.80.

A number of research firms recently issued reports on SEM. Wall Street Zen raised Select Medical from a “hold” rating to a “buy” rating in a report on Saturday, November 8th. Benchmark reaffirmed a “buy” rating on shares of Select Medical in a research note on Monday, October 27th. Mizuho set a $17.00 price target on shares of Select Medical in a research note on Monday, November 3rd. Weiss Ratings restated a “sell (d+)” rating on shares of Select Medical in a research report on Wednesday, October 8th. Finally, Royal Bank Of Canada increased their price objective on Select Medical from $16.00 to $20.00 and gave the company an “outperform” rating in a research report on Wednesday, October 8th.

Select Medical Stock Up 2.4%

Shares of SEM opened at $15.45 on Friday. The company has a market capitalization of $1.91 billion, a P/E ratio of 17.96, a PEG ratio of 0.53 and a beta of 1.26. Select Medical has a one year low of $11.65 and a one year high of $20.83. The business’s 50 day simple moving average is $14.68 and its 200-day simple moving average is $13.88. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.09 and a quick ratio of 1.09.

Select Medical (NYSE:SEM) last issued its quarterly earnings data on Thursday, October 30th. The health services provider reported $0.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.18 by $0.05. The firm had revenue of $1.36 billion during the quarter, compared to the consensus estimate of $1.33 billion. Select Medical had a return on equity of 7.41% and a net margin of 2.05%.The business’s revenue for the quarter was up 7.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.43 EPS. Select Medical has set its FY 2025 guidance at 1.140-1.240 EPS. As a group, sell-side analysts predict that Select Medical will post 1.17 EPS for the current fiscal year.

Select Medical Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, November 25th. Investors of record on Wednesday, November 12th were given a $0.0625 dividend. This represents a $0.25 dividend on an annualized basis and a yield of 1.6%. The ex-dividend date was Wednesday, November 12th. Select Medical’s dividend payout ratio (DPR) is presently 29.07%.

Institutional Investors Weigh In On Select Medical

Institutional investors have recently modified their holdings of the business. Allspring Global Investments Holdings LLC increased its position in shares of Select Medical by 10.0% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 25,472 shares of the health services provider’s stock valued at $377,000 after buying an additional 2,319 shares in the last quarter. Net Worth Advisory Group grew its stake in Select Medical by 13.4% in the fourth quarter. Net Worth Advisory Group now owns 16,920 shares of the health services provider’s stock valued at $251,000 after acquiring an additional 1,997 shares during the period. SG Americas Securities LLC increased its holdings in shares of Select Medical by 46.3% in the fourth quarter. SG Americas Securities LLC now owns 36,029 shares of the health services provider’s stock worth $535,000 after acquiring an additional 11,410 shares in the last quarter. Permanent Capital Management LP acquired a new stake in shares of Select Medical during the fourth quarter worth about $668,000. Finally, GAMMA Investing LLC lifted its holdings in shares of Select Medical by 147.9% during the 4th quarter. GAMMA Investing LLC now owns 4,713 shares of the health services provider’s stock valued at $70,000 after purchasing an additional 2,812 shares in the last quarter. Institutional investors and hedge funds own 89.48% of the company’s stock.

Select Medical Company Profile

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.